Skip to main content

Table 2 Analysis results for the association between epigenetic age acceleration and time to relapse

From: Time to relapse in chronic lymphocytic leukemia and DNA-methylation-based biological age

 

β [95% CI]

p

IEAA

− 0.01 [− 0.07, 0.05]

0.772

EEAA

− 0.06 [− 0.11, − 0.02]

0.011

PhenoAA

− 0.05 [− 0.09, 0.00]

0.046

GrimAA

0.15 [0.01, 0.30]

0.040

  1. Results are adjusted for chronological age at first treatment, sex, and chemoimmunotherapy regimen
  2. Beta coefficients represent the gain in time to relapse for each additional year of epigenetic age acceleration
Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us